What to Know About the Alzheimer Drug Aducanumab (Aduhelm)

JAMA Intern Med. 2022 Aug 1;182(8):892. doi: 10.1001/jamainternmed.2022.1039.
No abstract available

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Amyloid beta-Peptides
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Drug Approval
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • Amyloid beta-Peptides
  • Antibodies, Monoclonal, Humanized
  • aducanumab